Description

Companies clarify news articles about Jupiter Life Line's expansion plans and Emirates NBD's alleged acquisition of RBL Bank, confirming already disclosed information and denying unannounced negotiations.

Summary

BSE circular containing clarifications from two listed companies regarding news articles published on October 13-14, 2025. Jupiter Life Line Hospitals Limited clarified that news about their Rs 1,400 crore expansion push in Maharashtra was based on previously disclosed information. RBL Bank Limited denied reports about Emirates NBD preparing a $1.7 billion bid for majority control, stating the contents were incorrect and that no undisclosed negotiations warranting disclosure are taking place.

Key Points

  • Jupiter Life Line Hospitals Limited (JLHL, Code: 543980): Clarified news article dated October 13, 2025 on Moneycontrol about Rs 1,400 crore expansion to double capacity by 2029
  • All information in the article was already disclosed through earlier announcements and investor presentations
  • No new developments or ongoing negotiations that have not been previously disclosed
  • RBL Bank Limited (Code: 540065): Responded to news article dated October 14, 2025 in Economic Times about Emirates NBD preparing $1.7 billion acquisition bid
  • Bank stated the contents of the article are incorrect
  • Confirmed no undisclosed information that warrants disclosure under Regulation 30 at this stage
  • Bank routinely explores opportunities for shareholder value but such discussions do not warrant disclosure at preliminary stages
  • Both companies confirmed compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015

Jupiter Life Line Hospitals - Previously Disclosed Projects

Disclosed expansion projects referenced in clarification:

  1. Ghodbundar Mira Road, Thane (Disclosed: January 20, 2025)

    • Land purchased
    • Estimated Capex: Rs 400 crore
    • Capacity: 300 beds

  2. Pune Hospital (Disclosed: February 22, 2024)

    • Land acquired on lease
    • Capacity: 500 beds
    • Estimated Capex: Rs 500 crore

  3. Dombivli Hospital (Disclosed: September 12, 2023)

    • Capacity: 500 beds

  4. Investor Presentations containing expansion details:

    • Q1FY26 Results Presentation (August 1, 2025) - Page 8
    • Q4FY25 Results Presentation (May 9, 2025) - Page 12
    • Q3FY25 Results Presentation (February 7, 2025) - Page 9

Regulatory Context

  • Companies are required to make timely disclosures under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • Material events and developments must be disclosed to stock exchanges
  • Companies clarified that exploratory discussions or routine business activities do not necessarily warrant immediate disclosure
  • Both companies committed to making appropriate disclosures in a timely manner should any material developments occur

Compliance Requirements

  • Listed companies must respond to stock exchange queries regarding news articles that may impact stock prices
  • Companies must clarify whether reported negotiations or developments are accurate
  • If information is already in public domain through previous disclosures, companies must reference those disclosures
  • Companies must state whether they are aware of any undisclosed information that could explain unusual trading activity

Important Dates

  • October 13, 2025: Moneycontrol article on Jupiter Life Line expansion published
  • October 13, 2025: Jupiter Life Line submitted clarification
  • October 14, 2025: Economic Times article on RBL Bank acquisition published
  • October 14, 2025: RBL Bank submitted clarification

Impact Assessment

Market Impact: Low - No new material information disclosed that would significantly impact stock prices or trading decisions.

Operational Impact: Minimal - Routine regulatory compliance activity.

Investor Impact: Clarifies that Jupiter Life Line’s expansion plans are proceeding as previously announced with no change in timeline or investment amounts. For RBL Bank, investors are informed that acquisition reports are incorrect and no undisclosed negotiations are at a stage requiring disclosure.

Transparency: Both companies demonstrated commitment to regulatory compliance and transparent communication with stakeholders by promptly addressing news articles and providing comprehensive references to prior disclosures.

Impact Justification

Routine clarifications on news articles with no new material information disclosed; companies confirm compliance with existing disclosure obligations